Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 6, 2021 (Date of earliest event reported)     TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter)       Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number)   14201 Dallas Parkway Dallas , Texas 75254 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant’s telephone number, including area code)     Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Common stock $0.05 par value   THC   New York Stock Exchange 6.875% Senior Notes due 2031   THC31   New York Stock Exchange Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging Growth Company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.  ☐       Item 5.07. Submission of Matters to a Vote of Security Holders. The 2021 Annual Meeting of Shareholders of Tenet Healthcare Corporation (the “Company”) was held on May 6, 2021. Below are the final voting results from the meeting. 1. The Company’s shareholders elected the following nominees to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal:        FOR      AGAINST      ABSTAIN      BROKER NON- VOTES      APPROVAL PERCENTAGE   Ronald A. Rittenmeyer      88,372,426        3,413,599        453,932        7,084,266        96.3 %  J. Robert Kerrey      87,284,073        4,914,574        532,178        7,084,266        94.7 %  James L. Bierman      91,444,053        754,561        41,343        7,084,266        99.2 %  Richard W. Fisher      91,061,517        1,136,170        42,270        7,084,266        98.8 %  Meghan M. FitzGerald      91,146,979        1,061,976        31,002        7,084,266        98.8 %  Cecil D. Haney      92,043,687        154,092        42,178        7,084,266        99.8 %  Christopher S. Lynch      91,061,359        1,136,148        42,450        7,084,266        98.8 %  Richard J. Mark      91,467,949        727,917        44,091        7,084,266        99.2 %  Tammy Romo      91,073,057        1,138,033        28,867        7,084,266        98.8 %  Saumya Sutaria      91,009,512        1,198,949        31,496        7,084,266        98.7 %  Nadja Y. West      91,877,958        331,696        30,303        7,084,266        99.6 %  2. The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation:   FOR    AGAINST      ABSTAIN      BROKER NON- VOTES      APPROVAL PERCENTAGE   87,297,266      4,828,993        113,698        7,084,266        94.8 %  3. The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2021:   FOR    AGAINST      ABSTAIN      BROKER NON- VOTES      APPROVAL PERCENTAGE   98,201,144      1,073,130        49,949        —          98.9 %  SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     TENET HEALTHCARE CORPORATION Date: May 12, 2021   By:   /s/ Thomas Arnst   Name:   Thomas Arnst   Title:   Executive Vice President, Chief Administrative     Officer and General Counsel